technology. The contemporary presence of various structural groups that are individually active scaffolds of different typology of drugs, has directed us to speculate that these compounds may act as inhibitors of MDM2–p53 interaction. Therefore, both computational calculations and antiproliferative screening against A549 human lung adenocarcinoma cells and human SH-SY5Y neuroblastoma cells were carried
通过使用环境友好的微波技术,从
茚满基硝酮和 N-
乙烯基核碱基开始,通过区域和非对映选择性 1,3-偶极环加成反应,以非常好的收率合成了含有核碱基的
异恶唑烷,螺接在
茚满核上。当代存在的各种结构基团是不同类型药物的单独活性支架,使我们推测这些化合物可能作为 M
DM2-p53 相互作用的
抑制剂。因此,针对 A549 人肺腺癌细胞和人 SH-SY5Y 神经母细胞瘤细胞进行了计算计算和抗增殖筛选以支持这一假设。